Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of TOHOKU CHEMICAL CO.,LTD.. A complete text table follows the diagram.
Industry has a modest lead, while medical sales form a substantial second engine.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Industry sales group | 1 | 9.6B | 50.7% of reported total |
| Medical sales group | 1 | 8.0B | 42.4% of reported total |
| Academia, Life science sales group | 1 | 1.3B | 6.9% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Revenues From External Customers | 2 | 18.9B | Reported six-month total · ¥18.9B |
| Operating profit | 3 | 530M | 2.8% operating margin |
| Operating costs & expenses | 3 | 18.4B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 576M | Reported pretax result |
| TOHOKU CHEMICAL balances industrial and medical sales | 3 | 46M | Industry sales generated ¥9.61bn and medical sales ¥8.03bn, with academia and life science at ¥1.31bn. |
| Net profit attributable to owners | 5 | 396M | Reported parent-company result |
| Tax, attribution & other | 5 | 180M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Industry sales group | Revenues From External Customers | 9.6B |
| Medical sales group | Revenues From External Customers | 8.0B |
| Academia, Life science sales group | Revenues From External Customers | 1.3B |
| Other & rounding | Revenues From External Customers | 0 |
| Revenues From External Customers | Operating profit | 530M |
| Revenues From External Customers | Operating costs & expenses | 18.4B |
| Operating profit | Profit before tax | 530M |
| TOHOKU CHEMICAL balances industrial and medical sales | Profit before tax | 46M |
| Profit before tax | Net profit attributable to owners | 396M |
| Profit before tax | Tax, attribution & other | 180M |